Patents by Inventor Gregory M. Arndt

Gregory M. Arndt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR MONITORING COLORECTAL CANCER
    Publication number: 20100075304
    Abstract: Disclosed in this specification is a method for determining the stage of colorectal cancer by observing regulatory changes in select miRNA sequences. These sequences may include hsa-miR-31, hsa-miR-7, hsa-miR-99b, hsa-miR-378*, hsa-miR-133a, hsa-miR-125a and combinations of these sequences.
    Type: Application
    Filed: October 30, 2008
    Publication date: March 25, 2010
    Inventors: Mitch Raponi, Gregory M. Arndt
  • Emmprin antagonists and uses thereof
    Publication number: 20090028862
    Abstract: EMMPRIN (Extracellular Matrix Metalloproteinase Inducer) antagonists, such as antibodies, including specified portions or variants, siRNA, shRNA, antisense and DNAzymes, can be used to treat pathological processes associated with proliferative diseases, such as cancer, by specifically preventing or inhibiting the ability of proliferating tissue to develop a blood supply.
    Type: Application
    Filed: September 29, 2005
    Publication date: January 29, 2009
    Inventors: Gregory M. Arndt, Mehnaaz Lomas, Marian T. Nakada, Laurent P. Rivory, Yi Tang, Li Yan
  • Antagonist of TEB4 and Methods of Use
    Publication number: 20080090775
    Abstract: The invention concerns antagonists of TEB4 which have therapeutic activity in oncology applications and methods for selecting such antagonists
    Type: Application
    Filed: October 23, 2006
    Publication date: April 17, 2008
    Inventors: Chong Huang, Lillian Shahied-Arruda, Gregory M. Arndt
  • Double-stranded RNA-mediated gene suppression
    Publication number: 20020160393
    Abstract: The present invention relates to methods for modifying gene expression and in particular to methods for controlling gene expression in eukaryotic cells using double-stranded RNA (dsRNA), and to eukaryotic cell lines in which gene expression has been altered using the method. The invention also relates to compositions suitable for controlling gene expression and to methods of treatment which utilise such compositions.
    Type: Application
    Filed: December 28, 2001
    Publication date: October 31, 2002
    Inventors: Geoffrey P. Symonds, Gregory C. Fanning, Gregory M. Arndt, Mitch Raponi, Nham Trieu Tran